These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
654 related items for PubMed ID: 35469167
1. Lipid alterations in chronic liver disease and liver cancer. Paul B, Lewinska M, Andersen JB. JHEP Rep; 2022 Jun; 4(6):100479. PubMed ID: 35469167 [Abstract] [Full Text] [Related]
2. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. Wang M, Ma LJ, Yang Y, Xiao Z, Wan JB. Crit Rev Food Sci Nutr; 2019 Jun; 59(sup1):S116-S129. PubMed ID: 30580553 [Abstract] [Full Text] [Related]
3. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H, Xiong J. Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934 [Abstract] [Full Text] [Related]
4. The ménage à trois of autophagy, lipid droplets and liver disease. Filali-Mouncef Y, Hunter C, Roccio F, Zagkou S, Dupont N, Primard C, Proikas-Cezanne T, Reggiori F. Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741 [Abstract] [Full Text] [Related]
6. New targets for NAFLD. Parlati L, Régnier M, Guillou H, Postic C. JHEP Rep; 2021 Dec; 3(6):100346. PubMed ID: 34667947 [Abstract] [Full Text] [Related]
7. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N. Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [Abstract] [Full Text] [Related]
8. Conservation of lipid metabolic gene transcriptional regulatory networks in fish and mammals. Carmona-Antoñanzas G, Tocher DR, Martinez-Rubio L, Leaver MJ. Gene; 2014 Jan 15; 534(1):1-9. PubMed ID: 24177230 [Abstract] [Full Text] [Related]
9. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, Horiuchi A, Yamaura T, Umemura T, Sano K, Gonzalez FJ, Aoyama T, Tanaka E. BBA Clin; 2015 Jun 15; 3():168-74. PubMed ID: 26674248 [Abstract] [Full Text] [Related]
10. A human liver chimeric mouse model for non-alcoholic fatty liver disease. Bissig-Choisat B, Alves-Bezerra M, Zorman B, Ochsner SA, Barzi M, Legras X, Yang D, Borowiak M, Dean AM, York RB, Galvan NTN, Goss J, Lagor WR, Moore DD, Cohen DE, McKenna NJ, Sumazin P, Bissig KD. JHEP Rep; 2021 Jun 15; 3(3):100281. PubMed ID: 34036256 [Abstract] [Full Text] [Related]
11. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication. Israelsen M, Kim M, Suvitaival T, Madsen BS, Hansen CD, Torp N, Trost K, Thiele M, Hansen T, Legido-Quigley C, Krag A, MicrobLiver Consortium. JHEP Rep; 2021 Oct 15; 3(5):100325. PubMed ID: 34401690 [Abstract] [Full Text] [Related]
12. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism. Wang S, Sheng F, Zou L, Xiao J, Li P. J Adv Res; 2021 Dec 15; 34():109-122. PubMed ID: 35024184 [Abstract] [Full Text] [Related]
13. Regulation of energy metabolism by long-chain fatty acids. Nakamura MT, Yudell BE, Loor JJ. Prog Lipid Res; 2014 Jan 15; 53():124-44. PubMed ID: 24362249 [Abstract] [Full Text] [Related]
14. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features. Pabst T, Kortz L, Fiedler GM, Ceglarek U, Idle JR, Beyoğlu D. BBA Clin; 2017 Jun 15; 7():105-114. PubMed ID: 28331812 [Abstract] [Full Text] [Related]
15. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet. Kasbi-Chadli F, Ferchaud-Roucher V, Krempf M, Ouguerram K. Eur J Nutr; 2016 Mar 15; 55(2):589-599. PubMed ID: 25787885 [Abstract] [Full Text] [Related]
16. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease. McGlinchey AJ, Govaere O, Geng D, Ratziu V, Allison M, Bousier J, Petta S, de Oliviera C, Bugianesi E, Schattenberg JM, Daly AK, Hyötyläinen T, Anstee QM, Orešič M. JHEP Rep; 2022 May 15; 4(5):100477. PubMed ID: 35434590 [Abstract] [Full Text] [Related]
17. Maternal conjugated linoleic acid modulates TAG metabolism in adult rat offspring. Lavandera J, Gerstner CD, Saín J, Fariña AC, González MA, Bernal CA. Br J Nutr; 2017 Dec 15; 118(11):906-913. PubMed ID: 29173222 [Abstract] [Full Text] [Related]
18. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α. Liu T, Luo X, Li ZH, Wu JC, Luo SZ, Xu MY. World J Gastroenterol; 2019 Sep 28; 25(36):5451-5468. PubMed ID: 31576092 [Abstract] [Full Text] [Related]
19. Postpartum changes in maternal and infant erythrocyte fatty acids are likely to be driven by restoring insulin sensitivity and DHA status. Kuipers RS, Luxwolda MF, Sango WS, Kwesigabo G, Velzing-Aarts FV, Dijck-Brouwer DA, Muskiet FA. Med Hypotheses; 2011 Jun 28; 76(6):794-801. PubMed ID: 21388747 [Abstract] [Full Text] [Related]
20. Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels. Dahlhoff C, Worsch S, Sailer M, Hummel BA, Fiamoncini J, Uebel K, Obeid R, Scherling C, Geisel J, Bader BL, Daniel H. Mol Metab; 2014 Aug 28; 3(5):565-80. PubMed ID: 25061561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]